Deerfield Management Company as of Sept. 30, 2019
Portfolio Holdings for Deerfield Management Company
Deerfield Management Company holds 95 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Horizon Therapeutics | 7.2 | $176M | 6.5M | 27.23 | |
| Horizon Pharma Plc convertible security | 6.4 | $158M | 136M | 1.16 | |
| Mylan Nv | 6.2 | $151M | 7.7M | 19.78 | |
| Nevro Corp note 1.750% 6/0 | 5.3 | $131M | 116M | 1.13 | |
| Orchard Therapeutics Plc ads | 4.3 | $106M | 8.9M | 11.88 | |
| Homology Medicines | 4.2 | $104M | 5.8M | 18.10 | |
| Aerie Pharmaceuticals | 3.6 | $88M | 4.6M | 19.22 | |
| Rhythm Pharmaceuticals (RYTM) | 2.3 | $56M | 2.6M | 21.59 | |
| Brookdale Senior Living (BKD) | 2.2 | $55M | 7.2M | 7.58 | |
| Intersect Ent | 2.2 | $53M | 3.1M | 17.01 | |
| Acceleron Pharma | 2.1 | $52M | 1.3M | 39.51 | |
| Myokardia | 2.1 | $51M | 981k | 52.15 | |
| Intercept Pharmas conv | 2.0 | $50M | 58M | 0.86 | |
| Immunomedics | 1.7 | $43M | 3.2M | 13.26 | |
| Clovis Oncology Inc note 2.500% 9/1 | 1.7 | $42M | 49M | 0.86 | |
| Ra Pharmaceuticals | 1.7 | $41M | 1.7M | 23.65 | |
| Mirum Pharmaceuticals (MIRM) | 1.4 | $35M | 3.4M | 10.06 | |
| Kempharm Inc note 5.500% 2/0 | 1.3 | $33M | 62M | 0.52 | |
| Argenx Se (ARGX) | 1.3 | $32M | 281k | 113.96 | |
| Silk Road Medical Inc Common (SILK) | 1.3 | $32M | 980k | 32.53 | |
| Vericel (VCEL) | 1.3 | $32M | 2.1M | 15.14 | |
| Centene Corporation (CNC) | 1.3 | $31M | 720k | 43.26 | |
| Coherus Biosciences (CHRS) | 1.3 | $31M | 1.5M | 20.26 | |
| Fate Therapeutics (FATE) | 1.2 | $30M | 2.0M | 15.53 | |
| Alector (ALEC) | 1.2 | $30M | 2.1M | 14.42 | |
| Sarepta Therapeutics (SRPT) | 1.2 | $29M | 382k | 75.32 | |
| Select Medical Holdings Corporation (SEM) | 1.2 | $28M | 1.7M | 16.57 | |
| Blueprint Medicines (BPMC) | 1.1 | $28M | 377k | 73.47 | |
| Dbv Technologies S A (DBVT) | 1.1 | $28M | 3.2M | 8.60 | |
| Sientra | 1.1 | $27M | 4.1M | 6.48 | |
| Tandem Diabetes Care (TNDM) | 1.1 | $27M | 454k | 58.98 | |
| Editas Medicine (EDIT) | 1.1 | $26M | 1.2M | 22.74 | |
| Ptc Therapeutics Inc conv bd us | 1.1 | $26M | 25M | 1.04 | |
| Dfb Healthcare Acquistion Co unit 01/30/2023 | 1.1 | $26M | 2.5M | 10.32 | |
| Axogen (AXGN) | 0.9 | $23M | 1.8M | 12.48 | |
| Xeris Pharmaceuticals | 0.9 | $23M | 2.3M | 9.83 | |
| Springworks Therapeutics (SWTX) | 0.9 | $23M | 1.1M | 21.68 | |
| Molina Healthcare (MOH) | 0.9 | $22M | 197k | 109.72 | |
| Rocket Pharmaceuticals (RCKT) | 0.8 | $21M | 1.8M | 11.65 | |
| Addus Homecare Corp (ADUS) | 0.8 | $20M | 253k | 79.28 | |
| Deciphera Pharmaceuticals (DCPH) | 0.8 | $20M | 595k | 33.94 | |
| Arvinas Ord (ARVN) | 0.8 | $20M | 921k | 21.55 | |
| Mirati Therapeutics | 0.7 | $18M | 233k | 77.91 | |
| Humana (HUM) | 0.7 | $17M | 67k | 255.67 | |
| Wave Life Sciences (WVE) | 0.7 | $17M | 808k | 20.53 | |
| Ptc Therapeutics I (PTCT) | 0.7 | $16M | 471k | 33.82 | |
| Ardelyx (ARDX) | 0.7 | $16M | 3.4M | 4.70 | |
| Wright Medical Group Nv 2.25 20211115 | 0.7 | $16M | 14M | 1.17 | |
| Reata Pharmaceuticals Inc Cl A | 0.6 | $16M | 197k | 80.29 | |
| Galapagos Nv- (GLPG) | 0.6 | $15M | 101k | 152.66 | |
| Anaptysbio Inc Common (ANAB) | 0.6 | $15M | 425k | 34.99 | |
| Diplomat Pharmacy | 0.6 | $15M | 3.0M | 4.90 | |
| Turning Point Therapeutics I | 0.6 | $15M | 388k | 37.60 | |
| Audentes Therapeutics | 0.6 | $14M | 494k | 28.09 | |
| Syros Pharmaceuticals | 0.5 | $13M | 1.3M | 10.38 | |
| Global Blood Therapeutics In | 0.5 | $13M | 268k | 48.52 | |
| Flamel Technologies Sa (AVDL) | 0.5 | $11M | 2.7M | 4.16 | |
| Kiniksa Pharmaceuticals (KNSA) | 0.4 | $11M | 1.3M | 8.51 | |
| Kalvista Pharmaceuticals (KALV) | 0.4 | $10M | 891k | 11.60 | |
| Mallinckrodt Pub | 0.4 | $10M | 4.2M | 2.41 | |
| Inogen (INGN) | 0.4 | $9.2M | 192k | 47.91 | |
| Guardant Health (GH) | 0.3 | $8.0M | 126k | 63.83 | |
| BioCryst Pharmaceuticals (BCRX) | 0.3 | $7.9M | 2.8M | 2.86 | |
| eHealth (EHTH) | 0.3 | $7.3M | 110k | 66.79 | |
| AtriCure (ATRC) | 0.3 | $7.3M | 293k | 24.94 | |
| Aimmune Therapeutics | 0.3 | $7.1M | 340k | 20.94 | |
| Avrobio Ord (AVRO) | 0.3 | $7.1M | 500k | 14.12 | |
| X4 Pharmaceuticals (XFOR) | 0.3 | $7.2M | 564k | 12.71 | |
| Bridgebio Pharma (BBIO) | 0.2 | $6.2M | 290k | 21.47 | |
| Teligent Inc New bond | 0.2 | $5.5M | 9.6M | 0.58 | |
| Abiomed | 0.2 | $4.9M | 28k | 177.90 | |
| Medicines Company | 0.2 | $5.0M | 100k | 50.00 | |
| Forty Seven | 0.2 | $4.8M | 750k | 6.42 | |
| Provention Bio | 0.2 | $4.9M | 725k | 6.82 | |
| Igm Biosciences (IGMS) | 0.2 | $4.4M | 250k | 17.75 | |
| Alimera Sciences | 0.2 | $4.0M | 7.1M | 0.57 | |
| Aeglea Biotherapeutics | 0.2 | $3.8M | 500k | 7.69 | |
| Ideaya Biosciences (IDYA) | 0.2 | $3.8M | 423k | 9.00 | |
| Harpoon Therapeutics | 0.1 | $3.6M | 265k | 13.66 | |
| BioDelivery Sciences International | 0.1 | $3.4M | 816k | 4.21 | |
| Morphosys (MOR) | 0.1 | $3.4M | 125k | 27.47 | |
| Neuronetics (STIM) | 0.1 | $2.8M | 340k | 8.31 | |
| Alphatec Holdings (ATEC) | 0.1 | $2.7M | 537k | 5.02 | |
| Itamar Med | 0.1 | $2.7M | 314k | 8.75 | |
| Synlogic | 0.1 | $2.5M | 1.1M | 2.29 | |
| Agile Therapeutics | 0.1 | $1.9M | 1.6M | 1.18 | |
| Alpine Immune Sciences (ALPN) | 0.1 | $1.6M | 407k | 3.96 | |
| Castle Biosciences (CSTL) | 0.1 | $1.7M | 93k | 18.09 | |
| Viewray (VRAYQ) | 0.0 | $1.1M | 379k | 2.90 | |
| Eyenovia Inc equity (EYEN) | 0.0 | $729k | 197k | 3.70 | |
| Kempharm | 0.0 | $478k | 692k | 0.69 | |
| Neos Therapeutics | 0.0 | $475k | 321k | 1.48 | |
| Menlo Therapeutics | 0.0 | $446k | 100k | 4.48 | |
| Proteon Therapeutics | 0.0 | $319k | 1.2M | 0.26 | |
| Constellation Pharmceticls I | 0.0 | $152k | 24k | 6.44 |
